5.22. Analysis.
Comparison 5 Antiplatelet agents versus placebo/no antiplatelet for primary prevention (secondary outcomes), Outcome 22 Pregnancy with SAO (including maternal death, baby death, PE, SGA, preterm) ‐ IPD only.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.